SB INVESTMENT ADVISERS (UK) LTD

Holdings History for Vir Biotechnology, Inc. - Common Stock, $0.0001 par value (VIR)

Symbol: VIR on Nasdaq
Investment type: Equity / Common Stock, $0.0001 par value
Latest Disclosed Shares Owned: 13,116,977 shares
Security Ownership %: 9.4%

Shares, Excluding Options vs Price

Value, Excluding Options

SB Investment Advisers (UK) Limited ownership in Vir Biotechnology, Inc. Common Stock, $0.0001 par value (VIR)

17 Feb 2026 - SB Investment Advisers (UK) Limited has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 13,116,977 shares of Vir Biotechnology, Inc. Common Stock, $0.0001 par value (VIR). This represents 9.4% ownership of the company. This is the first filing by SB INVESTMENT ADVISERS (UK) LTD disclosing ownership of Vir Biotechnology, Inc. Common Stock, $0.0001 par value (VIR).

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
SB Investment Advisers (UK) Limited	9.4%		$77,652,504	13,116,977			$5.92	13G/A	31 Dec 2025	17 Feb 2026, 17:00

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0.79%	-0.22%	$79,095,371	13,116,977	-3,567,064	-21%	$6.03	Q4 2025
30 Sep 2025	0.72%	0%	$95,265,874	16,684,041	0		$5.71	Q3 2025
30 Jun 2025	0.67%	0%	$84,087,567	16,684,041	0		$5.04	Q2 2025
31 Mar 2025	0.99%	0%	$108,112,586	16,684,041	0		$6.48	Q1 2025
31 Dec 2024	1.1%	0%	$122,460,861	16,684,041	0		$7.34	Q4 2024
30 Sep 2024	1%	0%	$124,963,467	16,684,041	0		$7.49	Q3 2024
30 Jun 2024	1.4%	0%	$148,487,965	16,684,041	0		$8.90	Q2 2024
31 Mar 2024	1.7%	0%	$169,009,335	16,684,041	0		$10.13	Q1 2024
31 Dec 2023	1.5%	0%	$167,841,452	16,684,041	0		$10.06	Q4 2023
30 Sep 2023	1.3%	0%	$156,329,464	16,684,041	0		$9.37	Q3 2023
30 Jun 2023	3.1%	-0.31%	$409,259,526	16,684,041	-1,635,897	-8.9%	$24.53	Q2 2023
31 Mar 2023	3.5%	-0.37%	$426,304,957	18,319,938	-1,939,597	-9.6%	$23.27	Q1 2023
31 Dec 2022	4.3%	-0.39%	$512,768,831	20,259,535	-1,826,745	-8.3%	$25.31	Q4 2022
30 Sep 2022	3.3%	-0.02%	$425,823,000	22,086,280	-130,364	-0.59%	$19.28	Q3 2022
30 Jun 2022	4.5%	0%	$565,858,000	22,216,644	0		$25.47	Q2 2022
31 Mar 2022	2.7%	0%	$571,412,000	22,216,644	0		$25.72	Q1 2022
31 Dec 2021	2.7%	-0.05%	$930,211,000	22,216,644	-400,022	-1.8%	$41.87	Q4 2021
30 Sep 2021	3.1%	0%	$984,277,000	22,616,666	0		$43.52	Q3 2021
30 Jun 2021	2.1%	0%	$1,069,315,000	22,616,666	0		$47.28	Q2 2021
31 Mar 2021	2%	0%	$1,159,556,000	22,616,666	0		$51.27	Q1 2021
31 Dec 2020	2.4%	0%	$605,674,000	22,616,666	0		$26.78	Q4 2020
30 Sep 2020	6.7%	0%	$776,430,000	22,616,666	0		$34.33	Q3 2020
30 Jun 2020	10%	0%	$926,605,000	22,616,666	0		$40.97	Q2 2020
31 Mar 2020	8.4%	0%	$775,073,000	22,616,666	0		$34.27	Q1 2020
31 Dec 2019	3.1%	+3.1%	$284,405,000	22,616,666	+22,616,666	NEW	$12.58	Q4 2019

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.